FANCD2 associated with sporadic breast cancer risk

Carcinogenesis

Volumn 27, Issue 9, 2006, Pages 1930-1937

  Barroso, E ^a   Milne, R L ^a   Fernandez L P ^a   Zamora, P ^b   Arias, J I ^c   Benitez J ^a   Ribas, G ^a  

^a Centro Nacional de Investigaciones Oncológicas   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c Monte Naranco Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; FANCONI ANEMIA GROUP L PROTEIN; GENOMIC DNA; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; BINDING SITE; BREAST CANCER; CANCER RISK; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PHYLOGENY; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; STATISTICAL SIGNIFICANCE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; BASE SEQUENCE; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK; SPAIN;

EID: 33748172915     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl062     Document Type: Article

References (80)

1. Miki,Y., Swensen,J., Shattuck-Eidens,D. et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 266, 66-71.
2. Wooster,R., Bignell,G., Lancaster,J., Swift,S., Seal,S., Mangion,J., Collins,N., Gregory,S., Gumbs,C. and Micklem,G (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378, 789-792.
3. Howlett,N.G., Taniguchi,T., Olson,S. et al. (2002) Biallelic inactivation of BRCA2 in Fanconi anemia. Science, 297, 606-609.
4. Stewart,G. and Elledge,S.J. (2002) The two faces of BRCA2, a FANCtastic discovery. Mol. Cell, 10, 2-4.
5. Risch,N. (2001) The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol. Biomarkers Prev., 10, 733-741.
6. Antoniou,A.C., Pharoah,P.D., McMullan,G., Day,N.E., Ponder,B.A. and Easton,D. (2001) Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet. Epidemiol., 21, 1-18.
7. Antoniou,A.C. and Easton,D.F. (2003) Polygenic inheritance of breast cancer: Implications for design of association studies. Genet. Epidemiol., 25, 190-202.
8. Comings,D.E., Gade-Andavolu,R., Cone,L.A., Muhleman,D. and MacMurray,J.P. (2003) A multigene test for the risk of sporadic breast carcinoma. Cancer, 97, 2160-2170.
9. Liang,F., Han,M., Romanienko,P.J. and Jasin,M. (1998) Homology-directed repair is a major double-strand break repair pathway in mammalian cells. Proc. Natl Acad. Sci. USA, 95, 5172-5177.
10. Moynahan,M.E., Chiu,J.W., Koller,B.H. and Jasin,M. (1999) Brca1 controls homology-directed DNA repair. Mol. Cell, 4, 511-518.
11. Marmorstein,L.Y., Ouchi,T. and Aaronson,S.A. (1998) The BRCA2 gene product functionally interacts with p53 and RAD51. Proc. Natl Acad. Sci. USA, 95, 13869-13874.
12. Yuan,S.S., Lee,S.Y., Chen,G., Song,M., Tomlinson,G.E. and Lee,E.Y. (1999) BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo. Cancer Res., 59, 3547-3551.
13. Moynahan,M.E., Pierce,A.J. and Jasin,M. (2001) BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell, 7, 263-272.
14. Davies,A.A., Masson,J.Y., McIlwraith,M.J., Stasiak,A.Z., Stasiak,A., Venkitaraman,A.R. and West,S.C. (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol. Cell, 7, 273-282.
15. Digweed,M., Rothe,S., Demuth,I., Scholz,R., Schindler,D., Stumm,M., Grompe,M., Jordan,A. and Sperling,K. (2002) Attenuation of the formation of DNA-repair foci containing RAD51 in Fanconi anaemia. Carcinogenesis, 23, 1121-1126.
16. D'Andrea,A.D. and Grompe,M. (2003) The Fanconi anaemia/BRCA pathway. Nat. Rev. Cancer, 3, 23-34.
17. Wang,X. and D'Andrea,A.D. (2004) The interplay of Fanconi anemia proteins in the DNA damage response. DNA Repair (Amst), 3, 1063-1069.
18. Joenje,H., Oostra,A.B., Wijker,M. et al. (1997) Evidence for at least eight Fanconi anemia genes. Am. J. Hum. Genet., 61, 940-944.
19. Medhurst,A.L., Huber,P.A., Waisfisz,Q., de Winter,J.P. and Mathew,C.G. (2001) Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum. Mol. Genet., 10, 423-429.
20. Gordon,S.M. and Buchwald,M. (2003) Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. Blood, 102, 136-141.
21. Nakanishi,K., Moran,A., Hays,T., Kuang,Y., Fox,E., Garneau,D., de Oca,R.M., Grompe,M. and D'Andrea,A.D. (2001) Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9. Exp. Hematol., 29, 842-849.
22. Leveille,F., Blom,E., Medhurst,A.L. et al. (2004) The Fanconi anemia gene product FANCF is a flexible adaptor protein. J. Biol. Chem., 279, 39421-39430.
23. Meetei,A.R., de Winter,J.P., Medhurst,A.L. et al. (2003) A novel ubiquitin ligase is deficient in Fanconi anemia. Nat. Genet., 35, 165-170.
24. Meetei,A.R., Yan,Z. and Wang,W. (2004) FANCL replaces BRCA1 as the likely ubiquitin ligase responsible for FANCD2 monoubiquitination. Cell Cycle, 3, 179-181.
25. Meetei,A.R., Levitus,M., Xue,Y. et al. (2004) X-linked inheritance of Fanconi anemia complementation group B. Nat. Genet., 36, 1219-1224.
26. Fei,P., Yin,J. and Wang,W. (2005) New advances in the DNA damage response network of Fanconi anemia and BRCA proteins. FAAP95 replaces BRCA2 as the true FANCB protein. Cell Cycle, 4, 80-86.
27. Garcia-Higuera,I., Taniguchi,T., Ganesan,S., Meyn,M.S., Timmers,C., Hejna,J., Grompe,M. and D'Andrea,A.D. (2001) Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol. Cell, 7, 249-262.
28. Litman,R., Peng,M., Jin,Z., Zhang,F., Zhang,J., Powell,S., Andreassen,P.R. and Cantor,S.B. (2005) BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ. Cancer Cell, 8, 255-265.
29. Bridge,W.L., Vandenberg,C.J., Franklin,R.J. and Hiom,K. (2005) The BRIP1 helicase functions independently of BRCA1 in the Fanconi anemia pathway for DNA crosslink repair. Nat. Genet., 37, 953-957.
30. Meetei,A.R., Medhurst,A.L., Ling,C. et al. (2005) A human ortholog of archaeal DNA repair protein Hef is defective in Fanconi anemia complementation group M. Nat. Genet., 37, 958-963.
31. Morrison,C., Sonoda,E., Takao,N., Shinohara,A., Yamamoto,K. and Takeda,S. (2000) The controlling role of ATM in homologous recombinational repair of DNA damage. EMBO J., 19, 463-471.
32. Cliby,W.A., Roberts,C.J., Cimprich,K.A., Stringer,C.M., Lamb,J.R., Schreiber,S.L. and Friend,S.H. (1998) Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpoints. EMBO J., 17, 159-169.
33. Grompe,M (2002) FANCD2: A branch-point in DNA damage response? Nat. Med., 8, 555-556.
34. Taniguchi,T., Garcia-Higuera,I., Xu,B., Andreassen,P.R., Gregory,R.C., Kim,S.T., Lane,W.S., Kastan,M.B. and D'Andrea,A.D. (2002) Convergence of the fanconi anemia and ataxia telangiectasia signaling pathways. Cell, 109, 459-472.
35. Andreassen,P.R., D'Andrea,A.D. and Taniguchi,T. (2004) ATR couples FANCD2 monoubiquitination to the DNA-damage response. Genes Dev., 18, 1958-1963.
36. Venkitaraman,A.R. (2004) Tracing the network connecting BRCA and Fanconi anaemia proteins. Nat. Rev. Cancer, 4, 266-276.
37. Vandenberg,C.J., Gergely,F., Ong,C.Y., Pace,P., Mallery,D.L., Hiom,K. and Patel,K.J. (2003) BRCA1-independent ubiquitination of FANCD2. Mol. Cell, 12, 247-254.
38. Mantes de Oca,R., Andreassen,P.R., Margossian,S.P., Gregory,R.C., Taniguchi,T., Wang,X., Houghtaling,S., Grompe,M. and D'Andrea,A.D. (2005) Regulated interaction of the Fanconi anemia protein, FANCD2, with chromatin. Blood, 105, 1003-1009.
39. Park,W.H., Margossian,S., Horwitz,A.A., Simons,A.M., D'Andrea,A.D. and Parvin,J.D. (2005) Direct DNA binding activity of the Fanconi anemia D2 protein. J. Biol. Chem., 280, 23593-23598.
40. Hussain,S., Wilson,J.B., Medhurst,A.L. et al. (2004) Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways. Hum. Mol. Genet., 13, 1241-1248.
41. Taniguchi,T., Garcia-Higuera,I., Andreassen,P.R., Gregory,R.C., Grompe,M. and D'Andrea,A.D. (2002) S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. Blood, 100, 2414-2420.
42. Rothfuss,A. and Grompe,M. (2004) Repair kinetics of genomic interstrand DNA cross-links: Evidence for DNA double-strand break-dependent activation of the Fanconi anemia/BRCA pathway. Mol. Cell. Biol., 24, 123-134.
43. Howlett,N.G., Taniguchi,T., Durkin,S.G., D'Andrea,A.D. and Glover,T.W. (2005) The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum. Mol. Genet., 14, 693-701.
44. Wang,X., Andreassen,P.R. and D'Andrea,A.D. (2004) Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol. Cell. Biol., 24, 5850-5862.
45. Hussain,S., Witt,E., Huber,P.A., Medhurst,A.L., Ashworth,A. and Mathew,C.G. (2003) Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1. Hum. Mol. Genet., 12, 2503-2510.
46. Ohashi,A., Zdzienicka,M.Z., Chen,J. and Couch,F.J. (2005) Fanconi anemia complementation group D2 (FANCD2) functions independently of BRCA2- and RAD51-associated homologous recombination in response to DNA damage. J. Biol. Chem., 280, 14877-14883.
47. Nakanishi,K., Yang,Y.G., Pierce,A.J., Taniguchi,T., Digweed,M., D'Andrea,A.D., Wang,Z.Q. and Jasin,M. (2005) Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl Acad. Sci. USA, 102, 1110-1115.
48. Kuschel,B., Auranen,A., McBride,S. et al. (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum. Mol. Genet., 11, 1399-1407.
49. Kessler,H.H., Muhlbauer,G., Stelzl,E., Daghofer,E., Santner,B.I. and Marth,E. (2001) Fully automated nucleic acid extraction: MagNA Pure LC. Clin. Chem., 47, 1124-1126.
50. Barrett,J.C., Fry,B., Maller,J. and Daly,M.J. (2005) Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics, 21, 263-265.
51. StataCorp. (2003) Stata Statistical Software: Release 8.0TX: Stata Corporation, College Station.
52. Stephens,M., Smith,N.J. and Donnelly,P. (2001) A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet., 68, 978-989.
53. Stephens,M. and Donnelly,P. (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet., 73, 1162-1169.
54. Rozen,S. and Skaletsky,H. (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol. Biol., 132, 365-386.
55. Conde,L., Vaquerizas,J.M., Santoyo,J., Al-Shahrour,F., Ruiz-Llorente,S., Robledo,M. and Dopazo,J. (2004) PupaSNP Finder: A web tool for finding SNPs with putative effect at transcriptional level. Nucleic Acids Res., 32, W242-W248.
56. Loots,G.G. and Ovcharenko,I. (2004) rVISTA 2.0: Evolutionary analysis of transcription factor binding sites. Nucleic Acids Res., 32, W217-W221.
57. Ovcharenko,I., Nobrega,M.A., Loots,G.G. and Stubbs,L. (2004) ECR Browser: A tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res., 32, W280-W286.
58. Poirot,O., Suhre,K., Abergel,C., O'Toole,E. and Notredame,C. (2004) 3DCoffeeιgs: A web server for combining sequences and structures into a multiple sequence alignment. Nucleic Acids Res., 32, W37-W40.
59. Easton,D.F. (1994) Cancer risks in A-T heterozygotes. Int. J. Radiat. Biol., 66, S177-S182.
60. Thorstenson,Y.R., Roxas,A., Kroiss,R. et al. (2003) Contributions of ATM mutations to familial breast and ovarian cancer. Cancer Res., 63, 3325-3333.
61. Rodriguez-Lopez,R., Osorio,A., Sanchez-Pulido,L., De La Hoya,M., Barroso,A., Caldes,T. and Benitez,J. (2003) No mutations in the XRCC2 gene in BRCA1/2-negative high-risk breast cancer families. Int. J. Cancer, 103, 136-137.
62. Smith,T.R., Miller,M.S., Lohman,K., Lange,E.M., Case,L.D., Mohrenweiser,H.W. and Hu,J.J. (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett., 190, 183-190.
63. Meijers-Heijboer,H., van den Ouweland,A., Klijn,J. et al. (2002) Low-penetrance susceptibility to breast cancer due to CHEK2(* 1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat. Genet., 31, 55-59.
64. Folias,A., Matkovic,M., Bruun,D., Reid,S., Hejna,J., Grompe,M., D'Andrea,A. and Moses,R. (2002) BRCA1 interacts directly with the Fanconi anemia protein FANCA. Hum. Mol. Genet., 11, 2591-2597.
65. Levran,O., Attwooll,C., Henry,R.T. et al. (2005) The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia. Nat. Genet., 37, 931-933.
66. Venkitaraman,A.R. (2002) Connecting Fanconi's anaemia to breast cancer predisposition. Lancet, 360, 1344-1345.
67. Colleu-Durel,S., Guitton,N., Nourgalieva,K., Leveque,J., Danic,B. and Chenal,C. (2001) Genomic instability and breast cancer. Oncol. Rep., 8, 1001-1005.
68. Alter,B.P., Greene,M.H., Velazquez,I. and Rosenberg,P.S. (2003) Cancer in Fanconi anemia. Blood, 101, 2072.
69. Van Der Heijden,M.S., Brody,J.R. and Kern,S.E. (2004) Functional screen of the fanconi anemia pathway in cancer cells by Fancd2 immunoblot. Cancer Biol. Ther., 3, 534-537.
70. Turner,N., Tutt,A. and Ashworth,A. (2004) Hallmarks of 'BRCAness' in sporadic cancers. Nat. Rev. Cancer, 4, 814-819.
71. Lewis,A.G., Flanagan,J., Marsh,A., Pupo,G.M., Mann,G., Spurdle,A.B., Lindeman,G.J., Visvader,J.E., Brown,M.A and Chenevix-Trench,G. (2005) Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer. Breast Cancer Res., 7, R1005-R1016.
72. Holzel,M., van Diest,P.J., Bier,P., Wallisch,M., Hoatlin,M.E., Joenje,H. and de Winter,J.P. (2003) FANCD2 protein is expressed in proliferating cells of human tissues that are cancer-prone in Fanconi anaemia. J. Pathol., 201, 198-203.
73. Houghtaling,S., Timmers,C., Noll,M., Finegold,M.J., Jones,S.N., Meyn,M.S. and Grompe,M. (2003) Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev., 17, 2021-2035.
74. Houghtaling,S., Granville,L., Akkari,Y., Torimaru,Y., Olson,S., Finegold,M. and Grompe,M. (2005) Heterozygosity for p53 (Trp53+/-) accelerates epithelial tumor formation in fanconi anemia complementation group D2 (Fancd2) knockout mice. Cancer Res., 65, 85-91.
75. Seal,S., Barfoot,R., Jayatilake,H. et al. (2003) Evaluation of Fanconi Anemia genes in familial breast cancer predisposition. Cancer Res., 63, 8596-8599.
76. Thompson,E., Dragovic,R.L., Stephenson,S.A., Eccles,D.M., Campbell,I.G. and Dobrovic,A. (2005) A novel duplication polymorphism in the FANCA promoter and its association with breast and ovarian cancer. BMC Cancer, 5, 43.
77. Gabriel,S.B., Schaffner,S.F., Nguyen,H. et al. (2002) The structure of haplotype blocks in the human genome. Science, 296, 2225-2229.
78. Wang,N., Akey,J.M., Zhang,K., Chakraborty,R. and Jin,L. (2002) Distribution of recombination crossovers and the origin of haplotype blocks: The interplay of population history, recombination, and mutation. Am. J. Hum. Genet., 71, 1227-1234.
79. Kim,W.Y. and Kaelin,W.G. (2004) Role of VHL gene mutation in human cancer. J. Clin. Oncol., 22, 4991-5004.
80. Otis,C.N., Krebs,P.A., Albuquerque,A., Quezado,M.M., San Juan,X., Sobel,M.E. and Merino,M.J. (2002) Loss of heterozygosity of p53, BRCA1, VHL, and estrogen receptor genes in breast carcinoma: Correlation with related protein products and morphologic features. Int. J. Surg. Pathol., 10, 237-245.